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To: The President of the United States 
From: The Surgeon General of the United States 
RE: Amend the 1970 Controlled Substance Act to allow for the use of medical marijuana 
Date: December 10, 2014 
------------------------------------------------------------------------------------------------------------ 
Action forcing event:  
 
 Federal and State laws clash over marijuana legislation and regulatory 
jurisdiction.  The 1970 Controlled Substance Act (CSA) lists marijuana as a Schedule I 
drug.  This classification indicates marijuana has no accepted medical use and places it in 
the same lethal category as heroin, LSD, and ecstasy.  Possession of any form of the drug 
is a Federal crime, however, medical marijuana is legal in 23 states and DC.  This year, 
eleven additional states voted to ease restrictions on a non-intoxicating cannabis oil 
extract to allow for its use in research or as treatment against limited illnesses.  2014 also 
marked the year Colorado and Washington state began sales of recreational marijuana.  
This November, Oregon, Alaska, and DC will vote to do the same with similar state 
programs.  Just this spring, the House approved two initiatives to prevent federal 
incursion into state-run marijuana programs.  The two bills await Senate review 
scheduled for this fall.  Coinciding with their reviews is a House consideration of an 
additional bill seeking to amend the CSA with the removal of "therapeutic hemp and 
cannabidiol" marijuana from the CSA's Schedule I category.
1
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Statement of the Problem:  
 
 For many severely ill Americans, medical marijuana remains unavailable due to 
the Federal classification of the drug as a Schedule I narcotic.  In spite of the CSA 
classification declaring marijuana as having no medical use, a wide range of studies and 
patient testimonies reportedly support the drug's health benefits.
2
  Medical conditions that 
have shown positive results from trials of medical marijuana are notably cerebral palsy 
and other neurodegenerative diseases (i.e., Parkinson's disease and multiple sclerosis), 
cancer, HIV/AIDS, epilepsy and other conditions characterized by seizures, Alzheimer's 
disease, and post-traumatic stress disorder (PTSD).  Many seriously ill Americans with 
these diseases have found that medical marijuana is the most effective treatment against 
their affliction.  In many cases, it is the only medicine that works to alleviate the 
symptoms of their diseases.  It affords them unparalleled relief from pain without the 
debilitating side effects associated with Western or mainstream medicines and for many, 
it restores a quality of life taken from them by their illnesses.  However, due to a lack of 
Federal research focusing on the medicinal effects of marijuana, these claims remain 
unsubstantiated. 
 
 As it stands, ailing Americans suffering from these illnesses, residing outside of 
the 23 medical marijuana-legal states and DC, are denied participation in this form of 
treatment while it remains illegal in their home states.  Even if they were to travel to 
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obtain their medication from one of the 23 states or DC, crossing state borders in 
returning home with treatment is perceived as a federal trafficking violation of an illegal 
substance.  Such a violation would be subject to criminal prosecution with severe 
penalties.  This reality has forced countless patients to immigrate to a more accepting 
state so that they may ostensibly receive state protection for the use of their medication.  
However, not all who are afflicted can afford this option.  They must therefore resign to 
the FDA approved mainstream medicines, some of which produce adverse side effects 
that may rival symptoms of the affliction.   
 
 In addition to denying medicine to the severely ill, the federal ban on medical 
marijuana also forestalls comprehensive scientific research that perpetuates the absence 
of federal oversight and a national standard that is normally required of pharmaceuticals.  
Medical marijuana is not monitored like FDA-approved medicines.  National prohibition 
of medical marijuana ultimately harms America's seriously ill who suffer from their 
diseases unnecessarily.  It denies them a medical alternative that could potentially 
improve health and quality of life.  In some cases, it labels those legitimately ill, for 
whom this form of treatment may be the only viable answer, as criminals.  They are the 




 By the mid-1800s, the medicinal claims and uses of marijuana as medicine had 
curiously developed into a panacea for all ailments ranging from intestinal pain, to 
 4 
cholera, to strychnine poisoning, to bronchitis, whooping cough, and asthma.  And by the 
early 1900's its recreational use hit an all time high in the U.S.  The use of marijuana 
became so widespread that it gained the attention of State and Federal lawmakers.  
Regulating its handling became the natural recourse.  States began to outlaw marijuana 
starting with Massachusetts in 1911; Maine, Wyoming, and Indiana in 1913; New York 
City in 1914, Utah and Vermont in 1915, Colorado and Nevada in 1911.
3
  Federal 
regulations included the 1906 Pure Food and Drugs Act that incorporated marijuana in its 
mandate to label all medicine; the 1915 Harrison Act, although targeted opium 
production and international trade, inadvertently laid the groundwork for the 1937 
Marihuana Tax Act.
4
  In 1951, Congress declared the drug a narcotic and by 1970, the 
Controlled Substance Act declared it a Schedule I illegal substance. 
 
 Though marijuana wasn't nationally outlawed until 1970, the impetus for its 
prohibition can be linked to a late 1930's anti-marijuana movement.  The 1937 Taxation 
of Marijuana hearing before the House of Representative Ways and Means Committee, 
Harry Anslinger, the U.S. Narcotics Bureau Chief, referred to the drug as "evil weed."  In 
describing the effects of marijuana, Anslinger declared it induces "delirious rage after its 
administration, during which they [users] are temporarily, at least, irresponsible and 
liable to commit violent crimes."
 5
  He presented numerous accounts of the drug from 
experts of the time to discount marijuana as anything other than a threat to society.  It did 
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not take much to convince the public.  A much publicized movie, "Reefer Madness," had 
already established a platform for his anti-marijuana campaign, just one year prior.  The 
propaganda film linked incurable insanity and acts of violent crimes such as the rape and 
murder portrayed in its storyline with marijuana use.  In its forward before the film, it 
warned that while the story portrayed in the film may be fiction, it is "based upon actual 
research into the results of Marihuana addiction."
 6
  The film and Anslinger's anti-
marijuana campaign did much to rally public outcry and eventual legislation prohibiting 
the drug.  
 
 As Federal and State governments clamped down on marijuana use, public 
consensus swayed significantly in favor of prohibition.  Intensive research and studies to 
establish its harmful effects, not its therapeutic potential, ensued.  In spite of this, a 
significant amount of studies have revolved primarily around the attributes of two 
specific chemical components found in marijuana, delta-9-tetrahydrocannabinol (THC) 
and canabinidiol (CBD).  Considering that there are over 400 different chemical 
components found in marijuana,
7
 the ability of scientists to detail the qualities of only 
two after nearly a century of research further lends to the complexity of the plant.  Fully 
understanding marijuana is difficult given the levels of chemical compound variance 
present in each plant.  The concentration of chemicals in marijuana may fluctuate 
significantly from one genetic strain to another, from one growing environment to 
another, and from one part of the plant used to another.
8
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 Scientists have established that “THC is the main psychoactive ingredient in 
marijuana, and the one most responsible for its intoxicating effects.”
9
  The second most 
studied component in marijuana and is considered THC's primary countering agent is 
CBD.  “CBD is not intoxicating – CBD alone doesn't produce a high – but some claim it 
may calm the anxiety sometimes produced by high doses of THC.”
10
  It is the chemical 
agent CNN's Medical Correspondent, Dr. Sanjay Gupta, credits in his much publicized 
2012 documentary entitled “Weed” for effectively subduing the epileptic seizures of 
Charlotte Figi, a 5 year-old girl suffering from Dravet Syndrome.  It was Gupta's CNN 
documentary touting marijuana's medicinal properties that brought medical marijuana 
awareness to mainstream America.  Gupta tales the story of a non-intoxicating marijuana 
– one with enticing medical benefits that is high in CBD content and low in THC.  He 
reports scientists think that CBD quiets the excessive electrical and chemical activity in 
the brain that causes seizures making it an ideal drug for seizure causing illnesses.  The 
documentary energized the pro-medical marijuana movement and inspired a bill (the 
most recent of many) that was introduced in House this past July.  The bill dubbed 
Charlotte's Web Medical Hemp Act of 2014 seeks "to amend the Controlled Substances 
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 Moreover, scholarly studies in recent years and credible agencies ranging from 
the National Cancer Institute to The American College of Physicians have backed 
marijuana's medicinal attributes.
12
  Clinical studies have shown marijuana's effectiveness 
in relieving pain, controlling nausea and vomiting, and stimulating appetite in cancer and 
AIDS patients.
13
  A study performed just this year by the Guideline Development 
Subcommittee of the American Academy of Neurology discovered oral cannabis extracts 
reduced spasticity in multiple sclerosis patients while treating central pain or painful 
spasms.  
 
 The movement to legalize marijuana has also gained footing in Congress.  This 
spring, the House approved two measures to prevent federal incursion into state-run 
marijuana programs.  The States' Medical Marijuana Patient Protection Act secured a 
219-189 vote from the House in May and is awaiting Senate review for approval.  Its key 
argument is focused on the removal of marijuana as a Schedule I or Schedule II 
substance, and restricting federal funds from interfering with state marijuana programs.  
The second measure is the amendment to the Financial Services appropriations bill, 
approved by a 231-192 vote in the House.
14
  It blocks federal penalties against financial 
institutions that provide services to state-approved marijuana businesses.
15
  Both 
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measures still need Senate approval but their overwhelming support from the House is 
testament to the epic shift in public consensus and resulting momentum of the pro-
legalization reform movement. 
 
 Undeterred by the shift in popular consensus, clinical study findings, and recent 
pro-reform legislative gains, the Federal Government maintains that current studies on 
marijuana are inconclusive and that further research approved by the Food and Drug 
Administration (FDA) is required before marijuana can be taken off the Schedule I list 
and safely prescribed as medicine.  The Office of National Drug Control Policy 
(ONDCP) affirms marijuana as a Schedule I drug with a published Q&A fact sheet on its 
website stating marijuana has a “high potential for abuse and no currently accepted 
medical use in treatment in the United States.”
16
  It maintains that marijuana has not met 
the rigorous FDA approval process and that State actions to make it available for the 
public for medical and recreational use is inconsistent with Federal policy.  This notion 
was upheld in the DEA 2002 refusal of the Coalition for Rescheduling Cannabis' (CRC) 
request to reclassify marijuana from its Schedule I category.
 17
  The decision to deny a re-
class was also upheld by a United States Court of Appeals for the DC Circuit ruling in a 
follow-up lawsuit by a medical marijuana advocacy organization, Americans for Safe 
Access (ASA) in 2012.  The Senior Circuit Judge cited the lack of accepted studies that 
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would support marijuana's claim to medicine.
18
  Furthermore, ONDCP “evidence shows 
our drug problem is a major public health and safety threat, and drug addiction is a 
disease that can be successfully prevented and treated.  Legalizing drugs would increase 
their availability and normalize their use, leading to increased negative health 
consequences, particularly among young people. Drug legalization also undermines 
preventative health strategies, a keystone in improving overall public health in the United 
States.”
19
   
 
 Although Federal stance on marijuana legislation remains broadly firm, the 
Department of Justice (DOJ) and the U.S. Treasury have taken recent measures that 
contradict its affirmation.  Upon Colorado and Washington's move to legalize 
recreational marijuana last year, the DOJ responded in an August 2013 memorandum that 
“it would not veto Colorado and Washington's newly approved law, nor would it seek to 
prosecute dispensaries or businesses that sell small amounts of marijuana to adults.”
20
  
Likewise, the Treasury updated its guidelines allowing cannabis businesses in marijuana-
legal states to open bank accounts.  Additionally, in a step that relates to marijuana 
infractions the DOJ this year announced it would scale back prosecution against low-
level drug cases in an effort to reform the mandatory minimum sentencing laws.   
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 The Obama Administration has also opposed the reclassification of marijuana.  
The administration holds firmly to marijuana's defining addictive qualities and its threat 
to society.  However, in a January 2014 interview with The New Yorker, President 
Obama was quoted saying "I don't think it [marijuana] is more dangerous than alcohol."
 21
  
The comment was taken by many to show signs of a less than rigid stance. 
 
 In spite of all these pronouncements, marijuana is still classified as a Schedule I 




Key Players: The debate on the worth of medical marijuana is long-standing.  There are 
many stakeholders in this fight. However, the ones that are of most relevance to this 
policy are the Federal Government and their associated agencies (FDA, HHS, DEA, and 
NIDA), state representatives, the science and medical community, and the stakeholder 
with the most at stake - the profoundly ill.   
  
 The population size of America's severely ill is daunting.  The problem they face 
is real.  Some claim to have found unparalleled relief from their illnesses through 
legalized medical marijuana while others living in states that ban the drug are denied the 
same benefits.  The root of this inequality is the federal classification of marijuana as a 
Schedule I narcotic.  Categorizing marijuana in the most dangerous of five Schedules 
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accordingly identifies it as having "no currently accepted medical use and a high potential 
for abuse,"
 22
  Consequently, it mandates that any marijuana study be subjected to the 
most intense of Federal scrutiny.  Under the 1961 Single Convention on Narcotic Drugs 
policy,
23
 the Federal government is charged with providing marijuana for research.  By 
law, it is the only entity sanctioned to do so.  This monopoly on marijuana production 
enables the government to control the number and types of research conducted.  As a 
result, relatively few requests to research marijuana's therapeutic benefits have been 
approved since the 1970 Controlled Substances Act.  Ironically, the shortage of research 
resulting from the Federal government's control over production has enabled government 
entities the defense that more studies are needed before a rescheduling can be considered. 
 
 Obtaining federal approval for marijuana research has been a challenge 
historically.  The United States Department of Health and Human Services (HHS) is the 
primary key holder to any federally sanctioned research, testing, and eventual regulation 
of newly introduced drugs for pharmaceutical use.  For marijuana, a Schedule I drug, 
three federal agencies must preside over the approval process for research.  The Food and 
Drug Administration (FDA) manages and serves as the first approving agency for all 
applications requesting drug research;
24
  the National Institute on Drug Abuse (NIDA) 
maintains the research-grade marijuana that is required for any FDA approved studies 
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conducted on the drug; the Drug Enforcement Administration (DEA) provides site 
licensures and registrations for approved studies on all illegal substances.   
 
 This three-agency process has brought considerable criticism from researchers 
because much of the approved studies on marijuana have primarily focused on abuse and 
addiction.  Steven Gust, the special assistant to the director at NIDA, said "we've been 
studying marijuana since our inception.  Of course, the large majority of that research has 
been on the deleterious effects, the harmful effects, on cognition, behavior and so 
forth."
25
  It makes sense given NIDA's mission is to "lead the Nation in bringing the 
power of science to bear on drug abuse and addiction."
26
  Meanwhile, scientists and the 
millions suffering from ailments and illnesses that may benefit from impartial medical 
marijuana studies are left to other alternatives.   
 
 The 23 medical marijuana legal states and DC have chosen to abandon the 
lengthy federal research process.  Each state, relying on their own research authorities, 
have recognized several diseases and illnesses that qualify within their jurisdiction for 
marijuana treatment.  These approved medical conditions vary from state to state, but are 
primarily those that have shown positive results from individual clinical trials.  The list 
typically includes cerebral palsy and other neurodegenerative diseases (i.e., multiple 
sclerosis, Parkinson's disease), cancer, HIV/AIDS, epilepsy and other conditions 
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characterized by seizures, Alzheimer's disease, and post-traumatic stress disorder 
(PTSD).   
 
Multiple sclerosis: The number of ailing Americans currently suffering from marijuana 
qualified illnesses is daunting.  According to the National Multiple Sclerosis Society 
(NMSS), over 2.3 million people have multiple sclerosis (MS) nationwide.
27
  MS is a 
non-reportable disease, meaning doctors are not legally required to report newly 
diagnosed patients to a central data base.  For this reason, the count on new cases remain 
unconfirmed.  However, the NMSS indicates "more people are being diagnosed with MS 
today than in the past."
 28
  Symptoms may include "muscle stiffness, certain types of pain 
and muscle spasms, and overactive bladder."
 29
  However, NMSS claims these symptoms 
are treatable.  They state "an increasing number of studies suggest that derivatives of 
marijuana such as oral cannabis extract, sprays and pills may lessen patient reported MS 
symptoms like spasticity, pain related to spasticity, and frequent urination."
30
  NMSS 
acknowledges the need for further clinical studies.  Clinical trials are ongoing.  However, 
NMSS admits delays "due to challenges with recruiting patients able to adhere to the 
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Parkinson's disease: MS is a neurodegenerative disease, and while not all neurological 
disorders are treatable with marijuana, most scientists will agree that more scientific 
research is needed before it can be ruled out.
 32
  One such disorder is Parkinson's disease.  
The National Parkinson Foundation (NPF) reports over one million people are suffering 
from Parkinson's disease (PD) today while 50,000-60,000 new cases are being diagnosed 
each year.
33
  The NPF states "the few available studies revealed that marijuana was not 
helpful in Parkinson's disease related tremor or levodopa-induced dyskinesias."
 34
   In 
spite of this, several states (CT, IL, MA, NM, and NY)
 35
 have adopted PD to their list of 
marijuana authorized ailments. 
 
Cancer: There are countless millions suffering from various forms of cancer today.  The 
American Cancer Society (ACS) lists 75 different types of cancers on its webpage.
36
  The 
ACS asserts "more than one million people in the United States get cancer each year."
37
  
The most commonly recommended treatment for cancer today is chemotherapy.  
Although each patient's response to the treatment is unique, a predictable list of side 
effects can be expected.  Among them are severe pains that can last up to one year after 
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treatment in the form of "headaches, muscle pain, stomach pain, and pain from nerve 
damage, such as burning, numbness, or shooting pain."
38
  According to the National 
Cancer Institute, marijuana is reportedly effective in treating these pains.  It also indicates 
marijuana may help cancer patients find relief from "nausea and vomiting, anxiety, and 
loss of appetite."
 39
  This is relevant given chemotherapy can cause severe appetite loss 
leading to "weight loss, malnutrition, and loss of muscle mass and strength, which can 
hinder the body's ability to recover from chemotherapy."
40
  The Institute further states 
although more research is required, "cannabis has been shown to kill cancer cells in the 
laboratory and to affect the immune system."
41
  This gives promise to an entirely new 
application for marijuana in fighting cancer cells and further calls for more studies.    
 
HIV/AIDS: The Centers for Disease Control (CDC) reports the number of people living 
in the U.S. with HIV infection at 1.1 million.
42
  It estimates 50,000 new HIV cases are 
reported each year.  In 2010, 49,273 people were diagnosed with HIV while 32,052 were 
diagnosed with AIDS.
 43
  In the same year, 15,529 of those previously diagnosed with 
AIDS died.  Symptoms of HIV/AIDS resemble chemotherapy side effects.  They include 
nausea, lack of appetite leading to weight loss, nerve pain, and anxiety.  Accordingly, 
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medical marijuana has been shown to provide the same relief for HIV/AIDS symptoms as 




Epilepsy: According to Centers for Disease Control and Prevention (CDC), epilepsy 
costs the United States approximately $15.5 billion each year.
45
  Up to 3 million 
Americans suffer from epilepsy, while 65 million worldwide have some form of the 
disease.
46
  Over 150,000 new cases are diagnosed in the U.S. annually.
47
  An estimated 
50 thousand die in the U.S. each year from status epilepticus (prolonged seizures), 
Sudden Unexpected Death in Epilepsy (SUDEP), and other seizure-related causes such as 
drowning and other accidents.
48
  The Epilepsy Foundation reports 1 in 26 Americans will 
develop epilepsy and 1 out of 3 who develop the disease will live with uncontrolled 
seizures because no available treatment works for them.
49
  Dravet syndrome, Doose 
syndrome, Lennox Gastaute syndrome, and idiopathic early onset epilepsy are syndromes 
of epilepsy that affect children as young as infancy.
50
  SUDEP accounts for 34 percent of 
all sudden deaths in children.
51
  Five year old Charlotte Figi, the focus of CNN's 
documentary "Weed," went from having 300 seizures a week while on conventional 
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pharmaceuticals to having just 2 or 3 per month after switching to high CBD content 
medical marijuana.
52
  Her story sparked a modern day mass migration of families living 
with epilepsy to more medical marijuana friendly states.  The group is so large, they have 
been referred to as "medical marijuana refugees."
53
   
 
 Aside from epilepsy that directly effects children, the disease has also been 
reported among cases involving traumatic brain injuries (TBI).  Such injuries are found 
among sport related incidents and in troops returning from deployment.  An estimated 
440,000 soldiers returning from Iraq and Afghanistan have experienced TBI.
54
  
According to CURE, more than 100,000 of these soldiers will likely develop post-
traumatic epilepsy (PTE). 
 
 The millions of those suffering from profound illnesses are real.  The lack of 
federally funded medical research on the benefits of marijuana due to its classification as 
a Schedule I narcotic is evident.  Credible clinical studies outside the purview of the 
Federal Government testify to the therapeutic potential of medical marijuana.  Current 
federally approved medicines fail a great many of America's severely ill.  In fact, some 
diseases are "treatment-resistant."
55
 According to Compassionate Care New York, a fair 
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number of cases have proven that anti-epileptic drugs (AEDs) prescribed for children are 
ineffective.  In many of these cases, the prescribed AEDs induces mild to life-threatening 
side effects.  The milder side effects from AEDs include "hyperactivity, trouble sleeping, 
eye problems, weight gain, slowed thinking, fainting and heart rhythm changes."
56
  More 
life-threatening effects include "blistering and peeling of large areas of the skin (which 
can require hospitalization in a burn unit)."
57
  Those that have converted to medical 
marijuana have attested to trying an average of 12 other medications prior.  Medical 
marijuana is legal in 23 states and DC.  However, because it remains illegal in the 
remaining 27 states, a great majority of these severely ill Americans must resign to their 
conventional medicines.  Medicine for many that fail to fulfill its purpose for the patient 
or causes even more devastating side effects. 
 
Policy Proposal:  
 
 The Obama Administration, with counsel from the Attorney General, amends the 
1970 Controlled Substance Act to distinguish between marijuana and its non-
psychoactive cannabinoid derivatives so that therapeutic forms of marijuana may be 
excluded from Schedule I and not treated as a controlled substance under the CSA.  
Furthermore, this proposal recommends the Administration authorizes an increase in 
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federally sanctioned producers of research-grade therapeutic marijuana so that expanded 
clinical trials on marijuana's medicinal safety and efficacy might be maximized. 
 
 Cannabinoid derivatives are the bioactive components (THC, CBD, CBN) of the 
plant Cannabis sativa that displays a diverse range of therapeutic qualities.
58
  For the 
purpose of this proposal, therapeutic marijuana includes forms of the Cannabis plant 
typically with not more than .3 percent of the cannabinoid THC, the benchmark level 




 The purpose of this reclassification is to decriminalize the possession and use of 
cannabidiol (CBD) or therapeutic marijuana for the treatment of persons suffering from 
medical conditions identified as benefiting from the drug.  Excluding medical marijuana 
from the CSA would also eliminate the need for credentialed researchers to obtain 
medical-grade marijuana exclusively from NIDA, and thereby alleviating the time 
intensive process of requesting and acquiring from a single location. Aside from 
marijuana, no other controlled drugs are required to be issued by the federal government 
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 Currently, the NIDA Marijuana Project at the University of Mississippi is the sole 
supplier for all FDA approved research.
61
  For the sake of product consistency, every 
effort is made by the producer to standardize the chemical levels in every product.
62
  
Consequently, the high-THC, low-CBD marijuana strain produced at the federally 
sanctioned facility is the only strain available for research.  However, it is this controlled 
cultivation that has sacrificed the variety available for testing.  Moreover, any attempt by 
NIDA's grower now to crossbreed the marijuana plant to generate a product 
disproportionately higher in CBD would take years.
63
  Certifying additional suppliers 
specialized in therapeutic strains would eliminate this time-intensive process.  It would 
also allow for greater variety of immediate study and mitigate any shortages of the 
limited supplies.  More significantly, it would eliminate the current monopoly on research 
marijuana held by NIDA, an organization who's objective includes putting an end to 
abusive drugs. 
 
Policy Authorizing Tool:  The CSA grants the Attorney General power to adjust a drug's 
classification as needed.  Part B (Authority To Control; Standards And Schedules) of the 
CSA gives the Attorney General authority to "remove any drug or other substance from 
the schedules if he finds that the drug or other substance does not meet the requirements 
for inclusion in any schedule."
64
  Per the CSA, however, the Attorney General must first 
confer with the Secretary of Human and Health Services (HHS) to establish, modify, or 
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  A determination must be based on scientific or medical 
evidence.  In 2001 and 2006, HHS reviews were requested as a result of petitions to 
downgrade the classification of marijuana.  In both instances, HHS determined there were 
insufficient evidence to reclassify marijuana from Schedule I.
66
  Accordingly, the DEA 
has referred to these reviews in denying several subsequent requests to downgrade the 




 The petition process requiring an assessment and ruling from both HHS and DEA 
on marijuana scheduling may take years.  Case in point, the 2006 HHS review was in 
response to a 2002 petition filed by the Coalition for Rescheduling Cannabis.  The HHS 
and DEA review process took nine years to render a denial to the Coalition based on "a 




 Although per the CSA, an HHS assessment must be considered for any 
rescheduling of a listed substance, the requirement is that the DEA use it as 
recommendation only and not as actual grounds for denial.  Because the DEA, under 
authority from the Attorney General, must also conduct its own review to establish a 
drug's classification, as part of this policy proposal, it is recommended that the 
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Administration encourage a heavier reliance on other credentialed clinical studies and 
research evidence. 
 
Policy Implementation: Implementing an amendment to the CSA only requires action 
from the Administration.  The DEA acts on direction from the Attorney General.  The 
Attorney General is charged with dispensing his decision based on scientific or medical 
evidence.  According to the FDA, evidence is accurately deduced when the “gold” 
standard is applied to research.
69
  The FDA utilizes this standard in conducting clinical 
trials when testing a potential drug for safety and efficacy.
70
  This standard involves a 
“randomized, double-blind, placebo-controlled Phase III clinical trial”
71
 where 
knowledge on who actually receives the test drug or the placebo is withheld from both 
the study group and researchers administering the drug.  "Phase III" mandates the use of 
multiple test groups over an extended period of time.  In 2010, studies on smoked 
marijuana funded by the state of California using the “gold” standard provided evidence 
that “cannabis has analgesic effects in pain conditions secondary to injury (e.g. spinal 
cord injury) or disease (e.g. HIV disease, HIV drug therapy) of the nervous system.”
72
  
California's research also suggested marijuana reduces MS spasticity.
73
  Results from 
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these studies concluded marijuana effectively enhanced or exceeded the benefits of 
available pharmaceuticals.  Although the 2010 studies based its findings on smoked 
marijuana, it secured evidence using FDC protocol nevertheless.   
 
 Because medicine that requires the inhalation of potentially toxic fumes is highly 
doubtful to gain FDA endorsement, other forms of the drug are used in more recent 
studies (e.g., oils, sprays, and pills).  These “gold” standard studies may serve as 
additional resources for the mandated DEA review.  Ultimately, the “lack of available 
study” justification for denying an amendment to the CSA carries less weight when other 
highly accredited “gold” standard clinical studies are considered. 
 
Additional Note: Unlike previous petitions, this policy proposal does not suggest the 
Administration remove marijuana from Schedule I but rather segregate therapeutic 
marijuana from its traditional definition.  In doing so, the action averts violating any 
international conventions governing drug policy.  The Single Convention on Narcotic 
Drugs of 1961, the Convention on Psychotropic Drugs of 1971, and the UN Convention 
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988, requires 
any handling of marijuana (and other illicit drugs) outside of medical and scientific 
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Policy Analysis:  
  
Effectiveness (Con): The goal of this proposal is to provide effective treatment to 
patients with severe medical issues that don't currently have effective treatment.  At the 
present time, only 23 states and D.C. allow for medical marijuana.  Meanwhile, the 
severely ill that live outside the jurisdiction of these 23 states are denied access to the 
very treatment that has shown to be effective for those living in the 23 states.  This 
proposal proves effective if the act of lifting the nationwide ban on medical marijuana 
allows for universal access to those in need, regardless of their state of residence.  By this 
measure of effectiveness, the proposal is deficient.  By definition, an executive order is 
enforceable on federal entities only.  It lacks merit in application at the state level.  
Therefore, in spite of an executive order to authorize medical marijuana, state authorities 
may still choose to uphold the ban within their borders.  Consequently, for those who live 
in medical marijuana prohibited states, this policy will have little effect on their 
predicament.  In fact, for those patients crossing state lines in returning home (from 
medical marijuana states) with marijuana treatment, stiff state trafficking penalties would 
still apply.  In addition to state-level adherence concerns, given that this proposal relies 
on the president's executive authority, an obvious disadvantage is that the shelf-life of 
this policy may expire with the current administration. 
 
Effectiveness (Pro):  The counter to the above argument, however, is that recent polls 
show public approval of medical marijuana has increased significantly across the nation.  
A 2014 survey taken by the Pew Research Center indicated that 54 percent of Americans 
 25 
favor marijuana legalization while 42 percent oppose.
75
  This points to a change in 
overall consensus from just four years ago when 41 percent approved while 52 percent 
opposed.
 76
  Pew Research also revealed a large majority of the nation is now in favor of 
legalizing marijuana for medical use.  The survey reported 44 percent in favor, 39 percent 
agreed with legalizing it for personal use, while 16 percent disapproved legalizing 
marijuana for any manner of use.
77
  With public acceptance on the rise across the nation, 
state lawmakers can be expected to attune to their constituents.  There are signs of this 
already happening.  Based on a Pew Research Center analysis of data from the National 
Conference on State Legislatures and the Vera Institute between 2009 and 2013, forty 
States have chosen to revise their drug policies to show more leniency for those charged 
with drug crimes.
78
  Another clear indicator is the frequency at which the marijuana 
agenda has appeared on state ballots.  It is therefore within reason to forecast state level 
prohibitions reciprocating if the federal ban on medical marijuana was lifted. 
 
Effectiveness (Pro):  An additional advantage to this proposal is that it does not infringe 
upon any U.S. obligation to international drug policies.   This proposal seeks to delineate 
therapeutic marijuana from its conventional counterpart, not remove it completely from 
its Schedule I classification.  Removing or reclassifying a Schedule I substance from the 
CSA has global implications.  The 1961 Single Convention on Narcotic Drugs, an 
international agreement with 184 signatory country members, explicitly prohibits the 
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"production, trade, and possession of nonscientific and nonmedical narcotics a punishable 
offense."
79
  Considering the U.S. had already violated this convention once with 
Colorado and Washington's move to legalize recreational marijuana this year, a second 
violation within the same year (this time on a national level) would be ill advised.  
Therefore, by delineating therapeutic marijuana within the CSA, the U.S. remains 
compliant with international conventions.  
 
Effectiveness (Pro):  The FDA has taken this approach with marijuana before.  Marinol 
and Cesamet are synthetic THC based drugs on the market today.  Both are commonly 
prescribed to cancer patients for nausea and vomiting while undergoing chemotherapy.
80
  
Marinol is also prescribed to HIV patients as an appetite stimulant and for severe weight 
loss.
81
  Both are FDA endorsed synthetic oral drugs on the market today that were 
inspired by the THC found in marijuana.  Although Marinol and Cesamet are 
pharmaceuticals derived from a federally outlawed drug, its synthetic nature and given 
technical names (dronabinol and nabilone respectively) allow for it to be scheduled 
separately from marijuana under the CSA (both are listed as Schedule III substances).  
This technicality enables the FDA to authorize a cannabis-based drug while supporting 
the ban on marijuana. 
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Effectiveness (Con):  With FDA approved cannabis-based drugs on the market today, 
some would argue (with justification) that there is no need for therapeutic marijuana.  
The Pros and Cons of this argument is discussed more thoroughly in the political analysis 
section of this proposal.  However, in short, not all patients are responsive to Marinol and 
Cesamet.  Moreover, the side effects listed for these drugs are the very effects these drugs 
were created to treat.  For example, nausea and vomiting are among listed side effects for 
the use of Marinol.
82
  The chief complaint with Marinol and Cesamet, however, is that 
they lack other medicinal compounds (such as CBD) found naturally in marijuana.
83
  The 
downside of a drug based purely on the psychoactive component of marijuana makes it 
especially risky for several patient demographics. 
 
Effectiveness (Con):  With regards to this policy proposal's recommendation to increase 
the number of federally sanctioned producers - the goal is to increase the availability and 
variety of research-grade marijuana for greater research capacity.  It would also allow for 
a more expedited research marijuana acquisition process.  The current mandate requires 
scientists to obtain research marijuana from NIDA.  This has proven difficult and time 
intensive.  In easing medical marijuana's access to qualified researchers, more time could 
be allowed for relevant clinical studies. 
 
 Just as there are countless strains of marijuana in existence today, there are just as 
many cultivators.  Many are in the business of cultivating for recreational use and market.  
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However, some have aimed their products for use in the medical industry.  The Stanley 
Brothers, the Colorado-based cultivator that created the Charlotte's Web strain, is such a 
producer.  Their signature CBD infused strain has shown notable results against seizures 
exhibited in children with varying forms of epilepsy.
84
  By considering the Stanley 
Brothers company and other like producers as potential partners, the DEA could largely 
benefit the research process.   
 
Efficiency (Pro):  Timeliness is a factor given the growing number of those suffering and 
dying from severe illnesses.  Everyone on both sides of the marijuana legalization battle 
would agree that continuing studies are needed.  Authorizing more cultivators to provide 
research supply for approved studies lends to the efficiency of this policy goal.  In terms 
of time expended, this proposal cuts down the loss of valuable time normally consumed 
by the research application review and approval process managed by NIDA.  Using DEA 
approved cultivators would afford qualified researchers the opportunity to quickly access 
research marijuana.  Additionally, studying its therapeutic benefits as oppose to its 
adverse effects will no longer be a disqualifying criteria.  Thus, in bypassing NIDA's 
approval and supply process, valuable time is saved and greater research opportunities 
are afforded.  
 
Efficiency (Con):  Ideally, medical marijuana (as with any drug) should obtain FDA 
approval before being marketed.   While marijuana remains a Schedule I drug, no such 
approval can be expected.  This explains the reason why even within the medical-
                                                 
84
  Realm of Caring, "Charlotte's Web Hemp Products," 
http://theroc.us/index.php?option=com_content&view=article&id=57&Itemid=388, (Accessed: 22 
Nov) 
 29 
marijuana authorized States, marijuana treatment is "recommended" not "prescribed" by 
physicians.
85
  Although this policy proposal allows for the removal of medical marijuana 
from the CSA and increases the number of DEA certified suppliers of research-grade 
marijuana, it cannot reasonably force FDA to endorse the prescription of medical 
marijuana.  However, one may argue that FDA approval for treatment is not necessary for 
the severely ill to access it.  Under current conditions, therapeutic marijuana can be 
obtain irrespective of the FDA. 
 
Administrative Capacity (Pro): This initiative does not require any additional funding 
or manpower.  Enacting a new policy often necessitates the application of an 
implementation tool.  However, this policy proposal requires neither carrots, sticks, nor 
sermons.  It essentially calls for the removal of a tool - a stick.  Because marijuana is 
prohibited by federal law, enforcement of said laws required significant manpower and 
funding for the prosecution of violators, and housing of those eventually convicted.  By 
delisting medical marijuana from the CSA and subsequently eliminating the federal costs 
involved in enforcement and prosecution, money is made available for other federal 
concerns. 
 
Administrative Capacity (Con): This policy proposal recommends the introduction of 
additional producers to be used as suppliers of research-grade marijuana.  Although no 
additional funding is required, DEA responsibilities will extend to regulate these new 
producers accordingly.  Increased DEA involvement may initially be required for the 
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inspection and certification of said producers.  Upon designating qualified suppliers, the 
DEA would be required to conduct the review and inspection process.  This measure is 
solely to ensure compliance with DEA standards are met by new producers prior to 
enrollment into the federal program.  Periodic renewal and recertification will also be 
necessary.  NIDA's existing contract with the University of Mississippi as its sole 
supplier of marijuana is renewed every 5 years.
86
  Similar protocols will apply to new 
contracts.   
 
Equity/Fairness (Pro): The 1948 Universal Declaration of Human Rights sets the 
foundation on which patients' rights are grounded.
87
  In it, the UN acknowledges "the 
inherent dignity" and the "equal and unalienable rights of all members of the human 
family."
88
  The World Health Organization (WHO) refers to the UN Declaration in 
defining parameters for the treatment of patients.  In bridging the gap between human 
rights and the right to health, WHO declares "what is owed to the patient as a human 
being, by physicians and by the state, took shape in large part thanks to this 
understanding of the basic rights of the person."
 89
  Though WHO acknowledges the need 
for improvement in universally defining patients' rights, it correlates it with basic rights.  
Those rights include "equitable access to quality medical care"
90
 in providing for 
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 The goal of this policy proposal is in line with the World Health Organization's 
concept of patients' rights.  It seeks equitable medical rights and fairness for all seriously 
ill patients regardless of the state they reside in.  In other words, a multiple sclerosis 
patient residing in Florida (an anti-medical marijuana state) should have the same care 
afforded to those living in California (a pro-medical marijuana state).   
 
 This policy proposal is also in line with the masses with regards to the rights of 
physicians to provide the best care possible for their patients.  According to a survey 
conducted by the Social Science Research Solutions of Media for CBS News, 86 percent 
of the American population surveyed (January 2014) support a doctor's right to "prescribe 
small amounts of marijuana for patients suffering from serious illnesses."
92
   
 
Political Analysis:  
 
 There is no shortage of marijuana reform bills being pushed through Congress 
these days.  The recent increased frequency and resulting failure, however, only lends to 
further suggest that law makers within Congress are either obstinate on their stance 
against reform as a whole or simply dysfunctional.  Evidence proves the latter and further 
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underpins the need for executive influence.  Leaving this issue to Congress is not an 
option. 
 
Law makers: The same CBS poll that showed 86 percent of Americans support a 
doctor's right to prescribe medical marijuana also revealed significantly more Democrats 
than Republicans agree with marijuana reform.
93
  According to the poll, 59 percent of 
Democrats support marijuana reform while 61 percent of Republicans oppose it.
94
  This 
disproportion is also substantiated by the recent Gallup poll taken in October.  Gallup 
reported 64 percent of Democrats favored legalizing marijuana, while only 39 percent of 
Republicans do.
95
  The States' Medical Marijuana Patient Protection Act (H.R.689) that 
secured 219 votes from the House this past May illustrates this point well.  170 votes of 
the final 219 were from Democrats while the remaining 49 were from Republicans.
96
  
This bill may have overcome the House vote, but to also gain approval in the Senate is 
highly unlikely.  This is especially true if the Republicans take control of the Senate in 
the upcoming November mid-term election.   
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 It is worth noting, however, that H.R.689 serves as the first marijuana proposal to 
have ever been approved by a chamber of Congress.
97
  In fact, it and the House-approved 
amendment to the Financial Services appropriations bill (H.R.5016) that prevents the use 
of federal funds against state-approved marijuana programs (also passed this year) are 
clear indicators of the shift in constituent support for marijuana reform.  However, this 
does not change the fact that although Congress may have the capacity, it lacks the 
partisanship to wholly approve any reformation.  H.R.689 and H.R.5016 may have 
secured enough votes from the House to be submitted for review in the Senate, but their 
chances of becoming law are slim.  Using a formula that enlists statistics and factors, 





 respectively.  Because "only 11 percent of bills made it past committee and 
only about 3 percent were enacted in 2011-2013,"
100
 these two historical bills will most 
assuredly become yet two more to die. 
 
 According to Marijuana Policy Project (MPP), a lobby group active in ending 
prohibition, there are at least six active marijuana-related bills currently awaiting 
Congressional review.
101
  One bill in particular bares a semblance to this policy proposal.  
H.R.5226 - 113th Congress (2013-2014) dubbed Charlotte's Web Medical Hemp Act of 
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2014 maintains a theme parallel to this proposal in that it also seeks to segregate medical 
marijuana from its contemporary definition as it is written in the CSA.  Introduced July of 
this year by Rep. Scott Perry (R-PA), H.R.5226 seeks "to amend the Controlled 
Substances Act to exclude therapeutic hemp and cannabidiol from the definition of 
marijuana, and for other purposes."
102
  Like this proposal, the bill defines "therapeutic 
hemp" as high CBD, low THC (not more than .3 percent) and "cannabidiol" as the 
substance derived from therapeutic hemp.
103
  A House review has been scheduled, 
however, GovTrack.us only gives it a 7 percent chance of passing committee and a 3 




Media and the public: In spite of the countless failed Congressional attempts to pass a 
marijuana reform bill, the polls show public support for reform increasing.  The relatively 
recent political fervor of a mere handful of elected officials to side with reform is in part 
due to this growing public support.  Increased public support can be traced to the success 
of the media's ability to develop awareness.  Broadcast media and the Internet have been 
very instrumental in bringing the medical marijuana debate to mainstream America.  The 
2012 CNN documentary entitled "Weed" brought the plight of the severely ill to light for 
many.  It showed how effective the drug was in helping a five year old girl with epilepsy.  
The almost immediate therapeutic effect of taking cannabis oil for Charlotte Figi was 
clearly visible.  Her parents claimed it reduced the number of seizures she experienced 
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from 300 a week to just 1.
105
  The story and image this documentary portrayed was 
profound.  So much so that many proponents of reform refer back to it as reference on 
marijuana's potential as medicine. 
 
 Several other similar stories made popular by media further influenced a mass 
consensus and acceptance of medical marijuana use.  The CBS poll taken just this 
January provides a breakdown by demographics of those surveyed.  It reported growth in 
support among men and women up to the age of 65.
106
  Senior citizens 65 and up, though 
remained staunchly opposed to legalizing recreational marijuana, acknowledged their 
support for medical use nevertheless.
107
  Other demographics reviewed by the poll 
include those with annual incomes above and below $100 thousand.   From the last poll 
in April of 2013 to this recent January 2014 one, the percentage of supporters for 
marijuana legalization grew by 6 percent for those making less than $100 thousand (44% 
to 50%) while those making more showed a 12 percent increase in support (from 52% to 
64%).
108
   
 
Scientists: As mentioned, there are over 400 different chemicals found in marijuana.  
The complexity of the plant's makeup and the fact that each plant may significantly vary 
from one to the next has long kept scientists from completely understanding all of its 
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effects.  This anomaly further complicates research and hinders the FDA approval 
process in that pharmacology requires exactness.  The dosage of ingredients in one pill of 
a drug must match exactly the dosage of the next.  In the past, the inability to establish 
precise measurements, much less properly identify the effects of the multiple compounds 
found in marijuana has been a barrier to federal approval for commercial use all in itself.   
 
 Researchers acknowledge the need for more studies.  However, many attempts to 
initiate such studies have been denied by the Federal Government.  NIDA's tight hold on 
the only authorized source of research marijuana prevents access for many researchers 
attempting to examine the drug for its therapeutic potential.  And without research, 
marijuana will continue to remain a Schedule I lacking in accepted studies that would 
support the drug's claim to medicine. 
 
 The U.S. has fallen behind other countries in medical research involving 
marijuana.  Scientists in other countries have made some astonishing revelations with 
research into the benefits of marijuana.  In Spain, studies are being conducted to discover 
whether marijuana can kill cancer.  There, research using cannabinoids to target cancer in 
human subjects produced "anti-tumor responses."
109
  Aggressive brain tumors - the type 
that is "highly resistant to current anticancer treatment," showed signs of "autophagy,"
110
 
a term referring to the digestion of damaged structures within a cell.  Also, mice with 
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introduced human breast cancer cells showed an "anti-tumor response"
111
 to doses of 
THC.  Scientists there announced "THC, the major active component of marijuana, has 
anti-cancer properties."
 112
 It is worth noting that though this study involved the use of 
THC, "cannabinoid delivery was safe and could be achieved without overt psychoactive 
effects."
113
  The results are published in the British Journal of Cancer and the journal of 
Molecular Cancer Therapeutics.   
 
 In the UK, scientific research has led to the development of Sativex (technical 
name: nabiximols), a THC and CBD compound synthetic drug used to relieve cancer pain 
and multiple sclerosis symptoms.  The spray form of the drug was first introduced in 
Canada and the UK in 2010.  Upon its 2010 introduction by the two countries, it quickly 
gained approval for use in Spain, Czech Republic, Denmark, Germany, Sweden, Austria, 
Italy, New Zealand and Switzerland.
114
  The FDA, late to acknowledge Sativex, has since 
initiated investigations into its claims.  Phase III trials of an FDA approved process is 
scheduled for this year.
115
  However, the drug Sativex does comes with some drawbacks.  
Annual coverage prices for the drug could reach as high as $16,000 (US).
116
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 This policy proposal is a recommendation for executive action, not one that 
requests nor requires an act of Congress.  Putting this recommendation to Congress is not 
an option.  Due to the current political turmoil in Congress, as evident with the recent 
gridlock, passing a major marijuana law reform through both chambers would be as 
likely as achieving universal agreement on any major agenda from both political parties.  
Furthermore, this policy proposal does not recommend the legalization of recreational 
marijuana.  This proposal treats medical marijuana as a separate entity from its more 
habit forming cousin.  High CBD, low THC therapeutic marijuana is neither habit 
forming nor does it have the ability to induce intoxication.  The non-inhalant forms 
available today (oils, tincture, pills, and liquid) enables the avoidance of smoking the 
medicine - a method of introduction that may lead to harmful secondary effects. 
 
 The time is ripe for change.  Public support for medical marijuana is at an all time 
high.  If the President were to exert his executive powers to unilaterally amend the CSA 
by allowing for the end to the medical marijuana prohibition, he would have the backing 
of the American people. 
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 The President is no stranger to the use of his executive powers.  The President has 
relied on it to reduce power plant emissions,
118
 sign 23 separate gun control measures,
119
 
raised the minimum wage, acknowledged same-sex couples, and influence immigration 
policies.
120
  You vowed in January during a speech at North Carolina State University, 
saying "when I can act on my own without Congress, I'm going to do so."
121
  This policy 
presents an opportunity to do so.  Statistics indicate such a decision to delist medical 
marijuana from the CSA would have the backing of the masses.   
 
 Medical marijuana has caused considerable disparity between Federal and State 
government standings, law makers, the science and medical community, and between 
respective law enforcers and the severely ill.  The Federal government must see to the 
needs of the ailing millions who have been slighted and suffer needlessly.  Direct 
emphasis from the Administration is needed to end this disparity.  Reclassifying medical 
marijuana translates to providing effective treatment to patients with severe medical 
issues that don't currently have effective treatment.  It would also afford for 
comprehensive studies to discover every therapeutic benefit the drug may have to offer.  
In order to allow for a complete understanding of the complexity of therapeutic 
marijuana, its federal classification must be delisted from Schedule I and additional 
producers enrolled with DEA.  The CSA currently classifies marijuana as a Schedule I 
narcotic with no accepted medical use.  And while significant studies and clinical trials 
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have shown otherwise, most scientists and law makers on both sides agree that more 
studies are needed.  An amendment to the 1970 Controlled Substance Act is needed post 
haste if every aspect of medical marijuana is to be fully studied and exploited in time to 
help the millions that are now suffering.  Accordingly, the Federal government must 
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